Market News

AEye Q3 2026 mixed: revenue missed, EPS loss narrower, but Q4 revenue guidance fell below estimates and shares slipped after hours on weak outlook.

nLIGHT Q3 2026 results beat estimates on revenue and EPS, Q4 guidance tops consensus, but supply constraints delay some shipments into 2027.

AI shopping is growing fast but still a small part of the overall market; here’s what Morgan Stanley says matters before the holidays.

Kratos Q3 2026 revenue rose 35.7% but narrowly missed estimates; EPS beat, yet shares fell on cautious guidance and heavy investment.

Karat Q3 2026 revenue and EPS missed estimates on margin pressure; shares fell after hours despite e-commerce growth and maintained guidance.

Palantir stock is selling off despite another round of strong quarterly results. Where does the stock go from here?

Nvidia, CoreWeave, SpaceX plunged, but the stock market sell-off spread far beyond AI. The October jobs report looms.

Kronos Q3 2026 revenue was in line, while EPS beat on a non-cash tax benefit; TiO2 volumes rose 14% and prices increased 5% year over year.

Foodservice packaging supplier Karat Packaging (NASDAQ:KRT) missed Wall Street’s revenue expectations in Q3 2026, but revenue rose 8.2% year on year t...

KLX Energy Q3 2026 results were mixed: revenue in line at $185.6M, but non-GAAP EPS of -$0.44 missed consensus; no formal guidance issued.

2026-11-06. The following slide deck was published by JFrog Ltd.

Kayne Anderson BDC (KBDC) Q3 2026 EPS beat at $0.46, revenue inline; NAV fell, non-accruals rose, but $0.40 dividend coverage held despite weaker cred...

Key TakeawaysBloom Energy fell 16% today, even after NTT DATA agreed to deploy 900 megawatts of Bloom’s onsite power. Investors fear Democrats’ win in...

iRhythm Q3 revenue missed consensus but adjusted EPS beat; raised 2026 guidance, yet IRTC shares fell 15.5% after hours on soft sales and GAAP loss.

For questions about this article or underlying research, email [email protected].

Innodata Q3 2026 revenue and EPS crush consensus, full-year growth outlook raised; margin pressure and Q4 slowdown are key risks as shares rebound.

Profound Medical (PROF) delivered earnings and revenue surprises of -10.53% and +0.31%, respectively, for the quarter ended September 2026. Do the num...

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -64.87% and +9.43%, respectively, for the quarter ended September 2026. Do the...

Arlo Technologies (ARLO) delivered earnings and revenue surprises of +20.00% and +2.77%, respectively, for the quarter ended September 2026. Do the nu...

Quest Resource (QRHC) delivered earnings and revenue surprises of +33.33% and -4.81%, respectively, for the quarter ended September 2026. Do the numbe...